Affiliation:
1. National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Metabolic Syndrome Research Center, and Department of Metabolism and Endocrinology, Second Xiangya Hospital of Central South University , Changsha, 410011 Hunan , China
Abstract
Abstract
Context
Time-restricted eating (TRE), which restricts food intake to a limited duration of the day, is a key regimen of intermittent fasting.
Objective
The aim of our study was to provide an up-to-date meta-analysis and systematic review to evaluate the efficacy of TRE on weight loss and other metabolic-related parameters in adults.
Methods
We searched PubMed, EMBASE, and the Cochrane Library for relevant studies published before February 26, 2022. Study duration of TRE was at least 4 weeks. Body weight and other metabolic-related continuous parameters were described as weighted mean difference (WMD) with 95% CI.
Results
Seventeen randomized controlled trials involving 899 participants were analyzed. The pooled meta-analysis has shown that TRE contributed to a significant decrease in body weight with a WMD of −1.60 kg (95% CI −2.27 to −0.93) and fat mass with WMD −1.48 kg (95% CI −1.59 to −1.38). Subgroup analysis showed that TRE could reduce body weight and fat mass especially in overweight participants with WMD −1.43 kg (95% CI −2.05 to −0.81) and −1.56 kg (95% CI −1.67 to −1.44), respectively. TRE also showed beneficial effects on the lipid spectrum in overweight participants, including decreased levels of triglyceride (WMD −12.71 mg/dL, 95% CI −24.9 to −0.52), total cholesterol (WMD −6.45 mg/dL, 95% CI −7.40 to −5.49), and low-density lipoprotein cholesterol (WMD −7.0 mg/dL, 95% CI −9.74 to −4.25). However, compared with control, TRE had no significant effects on waist circumference, body mass index, glycosylated hemoglobin, or blood pressure.
Conclusion
This updated meta-analysis found that TRE may be an effective approach to improve the metabolic state of nonobese subjects, especially in overweight participants.
Funder
National Nature Science Foundation of China
National Key R&D Program of China
Subject
Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference63 articles.
1. Obesity: global epidemiology and pathogenesis;Blüher;Nat Rev Endocrinol,2019
2. Health effects of overweight and obesity in 195 countries over 25 years;Afshin;N Engl J Med,2017
3. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies;Wormser;Lancet,2011
4. Hypertension in obesity: novel insights;Natsis;Curr Hypertens Rev,2020
5. Hypertension in obesity: is leptin the culprit?;Simonds;Trends Neurosci,2013
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献